Related Experiment Video
Updated: Jun 24, 2026
10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Fine tuning the immune response with PI3K.
David A Fruman1, Georges Bismuth
1Department of Molecular Biology and Biochemistry, and Center for Immunology, University of California at Irvine, Irvine, CA, USA. dfruman@uci.edu
Immunological Reviews
|March 18, 2009
Summary
Phosphoinositide 3-kinase (PI3K) regulates lymphocyte behavior, development, and immune responses. Understanding PI3K
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- The phosphoinositide 3-kinase (PI3K) family of lipid kinases plays a critical role in regulating lymphocyte functions.
- PI3K signaling is essential for various stages of lymphocyte development, activation, and immune responses.
- Dysregulation of PI3K signaling can lead to immune system dysfunction and autoimmune diseases.
Purpose of the Study:
- To review the diverse roles of PI3K enzymes in lymphocyte biology.
- To discuss how genetic and pharmacological tools have advanced the understanding of PI3K function in lymphocytes.
- To highlight the complexities of PI3K signaling in maintaining immune homeostasis and its implications for therapeutic development.
Main Methods:
- Review of existing literature utilizing genetic and pharmacological approaches.
- Analysis of PI3K's role in B cell and T cell development and activation.
- Examination of PI3K's involvement in chemokine responsiveness, lymphocyte trafficking, and immune synapse formation.
Main Results:
- Class IA PI3K is crucial for B cell development and antigen responsiveness.
- Both class IA and IB PI3K are important for T cell development and function.
- PI3K signaling influences effector and regulatory T cell functions, impacting autoimmune phenotypes.
Conclusions:
- PI3K signaling is a complex network essential for proper immune responses and homeostasis.
- Imbalances in PI3K signaling can lead to autoimmune diseases.
- Further research is needed to fully define PI3K complexities for developing targeted therapies against inflammation and autoimmunity.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...